319 related articles for article (PubMed ID: 19741045)
1. Thyroid hormone receptors regulate adipogenesis and carcinogenesis via crosstalk signaling with peroxisome proliferator-activated receptors.
Lu C; Cheng SY
J Mol Endocrinol; 2010 Mar; 44(3):143-54. PubMed ID: 19741045
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of cross-talk between thyroid hormone and peroxisome proliferator activated receptors: focus on the heart.
Hyyti OM; Portman MA
Cardiovasc Drugs Ther; 2006 Dec; 20(6):463-9. PubMed ID: 17171294
[TBL] [Abstract][Full Text] [Related]
3. The IkappaBalpha gene is a peroxisome proliferator-activated receptor cardiac target gene.
Buroker NE; Barboza J; Huang JY
FEBS J; 2009 Jun; 276(12):3247-55. PubMed ID: 19438714
[TBL] [Abstract][Full Text] [Related]
4. Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation.
Liu YY; Brent GA
Trends Endocrinol Metab; 2010 Mar; 21(3):166-73. PubMed ID: 20015660
[TBL] [Abstract][Full Text] [Related]
5. PPARs: diverse regulators in energy metabolism and metabolic diseases.
Wang YX
Cell Res; 2010 Feb; 20(2):124-37. PubMed ID: 20101262
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptors and cancer: challenges and opportunities.
Youssef J; Badr M
Br J Pharmacol; 2011 Sep; 164(1):68-82. PubMed ID: 21449912
[TBL] [Abstract][Full Text] [Related]
7. The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention.
Peters JM; Shah YM; Gonzalez FJ
Nat Rev Cancer; 2012 Feb; 12(3):181-95. PubMed ID: 22318237
[TBL] [Abstract][Full Text] [Related]
8. [The role of peroxisome proliferator-activated receptors (PPAR) in carcinogenesis].
Knapp P; Jarzabek K; Błachnio A; Zbroch T
Ginekol Pol; 2006 Aug; 77(8):643-51. PubMed ID: 17076197
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between the thyroid hormone and peroxisome proliferator-activated receptors in regulating peroxisome proliferator-responsive genes.
Hunter J; Kassam A; Winrow CJ; Rachubinski RA; Capone JP
Mol Cell Endocrinol; 1996 Feb; 116(2):213-21. PubMed ID: 8647322
[TBL] [Abstract][Full Text] [Related]
10. The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis.
Hummasti S; Tontonoz P
Mol Endocrinol; 2006 Jun; 20(6):1261-75. PubMed ID: 16556736
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
Sertznig P; Seifert M; Tilgen W; Reichrath J
Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
[TBL] [Abstract][Full Text] [Related]
12. Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.
Sertznig P; Seifert M; Tilgen W; Reichrath J
J Cell Physiol; 2007 Jul; 212(1):1-12. PubMed ID: 17443682
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptors and renal diseases.
Wu J; Chen L; Zhang D; Huo M; Zhang X; Pu D; Guan Y
Front Biosci (Landmark Ed); 2009 Jan; 14(3):995-1009. PubMed ID: 19273113
[TBL] [Abstract][Full Text] [Related]
14. Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism.
Ross SE; Erickson RL; Gerin I; DeRose PM; Bajnok L; Longo KA; Misek DE; Kuick R; Hanash SM; Atkins KB; Andresen SM; Nebb HI; Madsen L; Kristiansen K; MacDougald OA
Mol Cell Biol; 2002 Aug; 22(16):5989-99. PubMed ID: 12138207
[TBL] [Abstract][Full Text] [Related]
15. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
[TBL] [Abstract][Full Text] [Related]
16. The Role of PPARs in Disease.
Wagner N; Wagner KD
Cells; 2020 Oct; 9(11):. PubMed ID: 33126411
[TBL] [Abstract][Full Text] [Related]
17. [PPARs: structure, mechanisms of action and control. Note I].
Filip-Ciubotaru F; Foia L; Manciuc C; Grigore C
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):477-84. PubMed ID: 21870744
[TBL] [Abstract][Full Text] [Related]
18. A review of the studies on food-derived factors which regulate energy metabolism via the modulation of lipid-sensing nuclear receptors.
Goto T
Biosci Biotechnol Biochem; 2019 Apr; 83(4):579-588. PubMed ID: 30572788
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of adipocyte differentiation by Nur77, Nurr1, and Nor1.
Chao LC; Bensinger SJ; Villanueva CJ; Wroblewski K; Tontonoz P
Mol Endocrinol; 2008 Dec; 22(12):2596-608. PubMed ID: 18945812
[TBL] [Abstract][Full Text] [Related]
20. Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling.
Gardner OS; Dewar BJ; Graves LM
Mol Pharmacol; 2005 Oct; 68(4):933-41. PubMed ID: 16020742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
